Literature DB >> 20688208

Cirrhotic cardiomyopathy.

Enrico M Zardi1, Antonio Abbate, Domenico Maria Zardi, Aldo Dobrina, Domenico Margiotta, Benjamin W Van Tassell, Benjamin W Van Tassel, Antonella Afeltra, Arun J Sanyal.   

Abstract

Cirrhotic cardiomyopathy is a clinical syndrome in patients with liver cirrhosis characterized by an abnormal and blunted response to physiologic, pathologic, or pharmacologic stress but normal to increased cardiac output and contractility at rest. As many as 50% of cirrhotic patients undergoing liver transplantation show signs of cardiac dysfunction, and 7% to 21% of deaths after orthotopic liver transplantation result from overt heart failure. In this review, we critically evaluate the existing literature on the pathophysiology and clinical implications of cirrhotic cardiomyopathy. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20688208     DOI: 10.1016/j.jacc.2009.12.075

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  77 in total

Review 1.  Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.

Authors:  Brian Erly; William D Carey; Baljendra Kapoor; J Mark McKinney; Mathew Tam; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

Review 3.  Does cirrhotic cardiomyopathy exist? 50 years of uncertainty.

Authors:  Pierpaolo Pellicori; Concetta Torromeo; Angela Calicchia; Alessandra Ruffa; Martina Di Iorio; John G F Cleland; Manuela Merli
Journal:  Clin Res Cardiol       Date:  2013-09-01       Impact factor: 5.460

4.  Non invasive continuous hemodynamic evaluation of cirrhotic patients after postural challenge.

Authors:  Roberto Tarquini; Gianluigi Mazzoccoli; Fulvio Fusi; Giacomo Laffi; Gian Franco Gensini; Salvatore Mario Romano
Journal:  World J Hepatol       Date:  2012-04-27

Review 5.  [Hepatocardiac disorders : Interactions between two organ systems].

Authors:  T Horvatits; A Drolz; K Rutter; K Roedl; S Kluge; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-06-13       Impact factor: 0.840

6.  Diastolic dysfunction characterizes cirrhotic cardiomyopathy.

Authors:  Piyush O Somani; Qais Contractor; Ajay S Chaurasia; Pravin M Rathi
Journal:  Indian Heart J       Date:  2014-07-23

7.  Fas Receptor Activation by Endogenous Opioids Is A New Mechanism for Cardiomyopathy in Cirrhotic Rats.

Authors:  Ata Abbasi; Negar Faramarzi; Mohsen Khosravi; Fatemeh Yazarloo; Mohammad Amin Abbasi; Ahmad R Dehpour; Issa Jahanzad
Journal:  J Clin Exp Hepatol       Date:  2016-10-17

Review 8.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 9.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

Review 10.  Outcomes of abdominal surgery in patients with liver cirrhosis.

Authors:  Juan C Lopez-Delgado; Josep Ballus; Francisco Esteve; Nelson L Betancur-Zambrano; Vicente Corral-Velez; Rafael Mañez; Antoni J Betbese; Joan A Roncal; Casimiro Javierre
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.